Skip to main content

Diabetes Mellitus: Pharmacotherapy-TZDs!

 PHARMACOTHERAPY: THIAZOLIDINEDIONES

  • Commonly referred to as TZDs or Glitazones,Thiazolidinediones have established a role in T2DM Therapy.

Mechanism of Action:

  • TZDs are known to increase insulin sensitivity by stimulating peroxisome proliferator-activated receptor gamma (PPAR-g). Stimulation of PPAR-g results in a number of intracellular and extracellular changes including increased insulin sensitivity and decreased plasma fatty acid levels.

Pharmacokinetics:

  • The onset of TZDs is delayed for several weeks and require up ton 12 weeks before maximum effects are observed.

Therapy:

  • As monotherapy, TZDs reduce FPG levels by around 60-70mg/dL and the effect of A1c is up to 1.5% reduction.


Clinical Uses:

  • Pioglitazone and Rosiglitazone increases HDL. Pioglitazone increases HDL by 5.2mg/dL Rosiglitazone increases HDL levels by 2-4mg/dL.
  • Pioglitazone decreases serum Triglycerides by an average of 51.9mg/dL. Rosiglitazone increases serum triglycerides.
  • Pioglitazone increases LDL levels by 12.3 mg/dL. Rosiglitazone increases LDL levels by 21.3mg/dL.


Adverse Effects:

  1. Fluid retention
  2. Edema
  3. Hepatotoxicity
  4. It is known that blood volume increases approximately 10% with these agents resulting in approximately 4-5% patients developing edema.


Contraindications:

These drugs are contraindicated in pt. with;

  • in situations in which increased fluid retention is detrimental such as heart failure.
  • Insulin therapy
  • Patients with a baseline alanine aminotransferase (ALT) level greater than 2.5 times the upper limit of normal.
  • Increased rate of upper and lower limb fractures tends to occur with TZD therapy, hence patients with baseline fracture risk are contraindicated to receive TZDs.
  • Premenopausal women may begin to ovulate on TZD therapy and therefore counselling should be provided to all women capable to begin pregnant regarding this.
  • TZD is pregnancy category C drug, so proper precautions to avoid pregnancy should be used.
  •   In June 2011, the FDA alerted healthcare providers and patients that pioglitazone was found to be associated with an increased risk of bladder cancer after 1 year of therapy in ongoing epidemiological study.
  • As 2007 meta-analysis conducted by Nissen and colleagues, reported that non-significant increase in myocardial infarction with Rosiglitazone compared with other oral agents.
  • A subsequent prospective study found Rosiglitazone use to be associated with a non-significant increase in Myocardial infarction risk and non-significant reduction in stroke, but a trend towards increased cardiovascular risk in those patients with Ischemic stroke.
  • In May 2011, the FDA chose to restrict access and distribution of Rosiglitazone. It is currently only available through the Avandia-Rosiglitazone Medicines access Program for patients currently benefiting from the drug and in those who cannot achieve adequate disease management with other agents or who are not willing to use pioglitazone-containing medications after counselling with their healthcare provider.



Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...
Post a Comment
Read more

Hospital Acquired Pneumonia- Definition, Predisposing Factors, Clinical Features and Management!

 HOSPITAL ACQUIRED PNEUMONIA Definition: "HAP refers to a new episode of pneumonia occurring at least 2 days after the administration to hospital. It is the most common Hospital Acquired Infection (HAI) and leading cause of HAI-associated death". Predisposing factors: Aspiration of nasopharyngeal secretion Bacteria introduced into the lower GIT. Bacteriaemia Old age Mode of Spread:  Droplet infection Infecting agent: Bacteria: S.pneumonia , S.aureus , H.influenza Virus: Adenovirus, Corona virus, Herpes Simplex Clinical Features: Purulent sputum New radiological infiltrates Temperature > 38 degree Celsius Leukocytosis Investigations: Chest Pain:  to confirm the diagnosis and exclude complication. Pulse Oximetry : to monitor response to oxygen therapy, if SaO2 < 93% features of sever pneumonia, identify ventilatory failure or acidosis. Cell count:  ESR, Neutrophil leukocytosis Microbiological studies:  for severe CAP and those that do not respond to ...
Post a Comment
Read more

Management of H.pylori and NSAID-associated ulcers Eradication!

MANAGEMENT FOR H.PYLORI ERADICATION It is known that H.pylori infection is associated with over 90% of duodenal ulcers and 80% of Gastric Ulcers. Antibiotics alone or acid-suppressing agents alone, do not eradicate H.pylori . Both therapies act synergistically as growth of the organism occurs at elevated pH and antibiotics efficacy is enhanced during growth. Additionally, increasing intragastric pH may enhance antibiotic absorption. High eradication rates are achieved by a short course of Triple Therapy consisting of:            1 .PPI                                         2. Clarithromycin                         3. Amoxicillin/Metronidazole          in a twice recommended simultaneous regimen. First-Line Therapy :  European Guidelines recommended 1 we...
Post a Comment
Read more